Sigma Healthcare leadership says it has received no worker reports of medicine mishandling

16 May 2019 - Sigma Healthcare's chief executive Mark Hooper has told investors that the company takes its obligations to ...

Read more →

Sigma Healthcare to face investor questions over claims it mishandled prescription drugs

15 May 2019 - Pharmaceutical supplier Sigma Healthcare will face shareholder questions over claims that it failed to properly handle ...

Read more →

Medicines Australia welcomes ALP R&D investment pledge

8 May 2019 - Medicines Australia welcomes today’s announcement from the Australian Labor Party to reform the Research and Development ...

Read more →

Newly approved MS drug to offer relief to children

1 May 2019 - A wonder drug to treat children with multiple sclerosis has been approved for use in Australia. ...

Read more →

Aytu BioScience announces submission of ZolpiMist for approval to Australian TGA

24 April 2019 - Australian TGA approval decision expected in early 2020. ...

Read more →

Labor to fast-track leukaemia drug trials

17 April 2019 - Patients with deadly blood cancers will get faster access to potentially life-saving drug trials if Labor ...

Read more →

International work-sharing initiative - abemaciclib (Verzenio)

9 April 2019 - Abemaciclib (Verzenio) is the second medicine to be registered on the Australian Register of Therapeutic Goods ...

Read more →

The stepped wedge cluster randomised trial: what it is and when it should be used

1 April 2019 - The basic premise of a stepped wedge cluster randomised trial is that all clusters start in the ...

Read more →

New early breast cancer drug to reduce risk of recurrence or death approved for Australian women

18 March 2019 - Nerlynx (neratinib) now approved by the Therapeutic Goods Administration for Australian women. ...

Read more →

Brexit - implications for therapeutic goods in Australia

18 March 2019 - In the event of a 'no deal' exit of the United Kingdom from the European Union, ...

Read more →

Vertex receives approval for Symdeko (tezacaftor/ivacaftor and ivacaftor) in Australia, to treat the underlying cause of cystic fibrosis in people aged 12 and older with certain CFTR gene mutations

12 March 2019 - A new treatment option for patients with two copies of the F508del mutation, the most common mutation ...

Read more →

Cluster randomised trials

4 March 2019 - Cluster randomised trials randomise groups of individuals rather than individuals themselves to interventions.  ...

Read more →

Whether the TGA should publish that a prescription medicine is under evaluation

15 February 2019 - The TGA is seeking comments from interested parties on whether or not the TGA should in future ...

Read more →

New weight loss pill launched in Australia

14 February 2019 - A new medication to help fight obesity has been launched in Australia. ...

Read more →

Sweet smell of success for patients taking the sugar pill

15 January 2019 - A placebo is anything that seems to offer a real medical treatment, but doesn’t. It could ...

Read more →